683 Capital Management, LLC In8 Bio, Inc. Transaction History
683 Capital Management, LLC
- $1.1 Billion
- Q3 2024
A detailed history of 683 Capital Management, LLC transactions in In8 Bio, Inc. stock. As of the latest transaction made, 683 Capital Management, LLC holds 1,350,304 shares of INAB stock, worth $459,103. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,350,304
Previous 590,811
128.55%
Holding current value
$459,103
Previous $502,000
27.49%
% of portfolio
0.03%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding INAB
# of Institutions
26Shares Held
7.57MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD1.67MShares$569,3760.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$484,1240.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI851KShares$289,4350.01% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT829KShares$281,9190.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL435KShares$147,8350.0% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $8.33M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...